Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2012
08/08/2012EP1297169B1 Method for transfecting cells using a magnetic field
08/08/2012CN102628047A Nucleic acid aptamer rich in guanine and application thereof
08/08/2012CN102628046A Nucleic acid aptamer rich in guanine
08/08/2012CN102628044A RNAi modulation of APOB and uses thereof
08/08/2012CN101935651B siRNA module of targeted Survivin gene and application thereof
08/08/2012CN101935649B SiRNA (Small Interfering RNA) molecule capable of suppressing Survivin expression and application thereof
08/08/2012CN101928747B Application of E3 ubiquitin ligase CHIP in gliomatosis cerebri disease
08/08/2012CN101920009B Vaccine for preventing and curing tumor
08/08/2012CN101892235B MicroRNA used for inducing leukemia cell differentiation
08/08/2012CN101658527B Composition for suppressing target gene expression
08/08/2012CN101516902B Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
08/08/2012CN101151371B Retrotransposon inhibition in therapy
08/08/2012CN101092636B Selectively replicating viral vectors, preparation method and application
08/08/2012CN101020055B SARS vaccine based on replicative vaccinia virus vector
08/07/2012US8236944 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
08/07/2012US8236777 MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
08/07/2012US8236776 Modified CEA nucleic acid and expression vectors
08/07/2012US8236774 Human telomerase catalytic subunit
08/07/2012US8236772 Methods of modulating angiogenesis and screening compounds for activity in modulating angiogenesis
08/07/2012US8236771 Vectors and methods for long-term immune evasion to prolong transplant viability
08/07/2012US8236770 Serum-stable amphoteric liposomes
08/07/2012US8236751 Methods of increasing muscle mass using follistatin-like related gene (FLRG)
08/07/2012US8236558 Bovine immunodeficiency virus (BIV) based vectors
08/07/2012US8236541 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
08/07/2012US8236510 Protein showing enhanced expression in cancer cells
08/07/2012US8236507 Modulators of TNF receptor associated factor (TRAF), their preparation and use
08/07/2012US8236296 Biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart
08/07/2012US8236295 Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses
08/07/2012US8236294 Gene therapy using transposon-based vectors
08/07/2012US8236293 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
08/07/2012CA2524258C Carrier complexes comprising cationic peptides for delivering molecules to cells
08/07/2012CA2457652C Soluble t cell receptor
08/07/2012CA2457414C Virus coat protein/receptor chimeras and methods of use
08/07/2012CA2456516C Identification of a dna variant associated with adult type hypolactasia
08/07/2012CA2447367C Diagnosis and treatment of malignant neoplasms
08/07/2012CA2445421C Von willebrand factor (vwf)-cleaving protease
08/07/2012CA2402213C Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant
08/07/2012CA2319715C Breast cancer resistance protein (bcrp) and the dna which encodes it
08/02/2012WO2012103163A2 Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathy
08/02/2012WO2012103019A2 Treating neuropsychiatric disorders
08/02/2012WO2012102793A2 Mammalian genes involved in toxicity and infection
08/02/2012WO2012102527A2 Novel use of regulatory t cell-specific surface protein lrig-1
08/02/2012WO2012100384A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof
08/02/2012WO2012054365A3 Novel low molecular weight cationic lipids for oligonucleotide delivery
08/02/2012WO2012053741A9 Nucleic acid molecules inducing rna interference, and uses thereof
08/02/2012WO2012006145A3 Com positions and methods for retargeting virus constructs
08/02/2012WO2012003287A3 Compositions and methods for detecting and quantifying circulating tumor cells ctcs
08/02/2012US20120197114 Nanocarriers for imaging and therapy applications
08/02/2012US20120196924 METHODS AND PRODUCTS FOR EXPRESSION OF MICRO RNAs
08/02/2012US20120196921 Modulation of sglt-2 expression
08/02/2012US20120195988 Therapeutic Uses for Plants of the Capsicum Genus
08/02/2012US20120195959 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin
08/02/2012US20120195947 Protein nanocarriers for topical delivery
08/02/2012US20120195927 Gm-negative ehv-mutants without heterologous elements
08/02/2012US20120195866 PKD Ligands and Polynucleotides Encoding PKD Ligands
08/02/2012US20120195865 Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
08/02/2012US20120195852 Vaccines, immunotherapeutics and methods for using the same
08/02/2012CA2825573A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof
08/01/2012EP2481800A2 Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof
08/01/2012EP2481750A1 B7-DC binding antibody
08/01/2012EP2481748A2 Foxp3 peptide vaccine
08/01/2012EP2480669A2 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
08/01/2012EP1797183B1 Regulation of oncogenes by micrornas
08/01/2012EP1766082B1 Cog47 protein and s100beta gene polymorphism
08/01/2012EP1553966B1 Fusion peptides comprising the human papillomavirus e7 and e6 polypeptides and immunogenic compositions thereof
08/01/2012EP1369133B1 Gene carriers comprising a beta-1,3-glucan and process for producing the same
08/01/2012EP1328653B1 Highly expressible genes
08/01/2012EP1181057B1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
08/01/2012CN102625841A Treatment of Adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an Adiponectin (ADIPOQ)
08/01/2012CN102618577A Enhanced tumor-specific therapy vector
08/01/2012CN102618562A Neukinase, a downstream protein of neuregulin
08/01/2012CN102618541A Compositions for treating respiratory viral infections and their use
08/01/2012CN102618535A Nucleotides, recombinant vector comprising nucleotides, cell, composition, and application of recombinant vector, cell and composition
08/01/2012CN102618507A Recombinant adeno-associated virus increasing targeted transduction efficiency of adeno-associated virus, and application of recombinant adeno-associated virus
08/01/2012CN102617739A Novel method for preventing or treating M tuberculosis infection
08/01/2012CN102617712A Polypeptide for effectively restraining activity of influenza virus polymerase
08/01/2012CN102614529A Drug delivery system for treating nasopharyngeal carcinoma (NPC) and construction method and application method thereof
08/01/2012CN102614528A Polyconjugates for in vivo delivery of polynucleotides
08/01/2012CN102614527A Antiacid nano oral deoxyribonucleic acid (DNA) anti-tumor vaccine with potential of hydrogen (pH) sensitive characteristic and preparation method
08/01/2012CN102614526A Cross-protection DNA vaccine
08/01/2012CN102614525A Protein-mediated brain-targeting gene delivery system and application thereof
08/01/2012CN102614524A Brain tumour targeting gene delivery composite modified by low density lipoprotein receptor associated protein ligand polypeptide
08/01/2012CN101880328B Th multi-epitope gene and fusion protein of cryptosporidium parvum and application thereof
08/01/2012CN101184511B Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen
08/01/2012CN101091797B Method for taking off endotoxin in primary pure plasmids or proteins, and kit
07/2012
07/31/2012US8232386 SiRNA targeting apolipoprotein B (APOB)
07/31/2012US8232385 siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
07/31/2012US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
07/31/2012US8232379 Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
07/31/2012US8232260 In vivo production of small interfering RNAs that mediate gene silencing
07/31/2012US8232255 Methods for vaccinating against malaria
07/31/2012US8231862 RBP4 in insulin sensitivity/resistance, diabetes, and obesity
07/31/2012CA2526831C Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)
07/31/2012CA2449999C Compounds and methods for the treatment or prevention of flavivirus infections
07/31/2012CA2411919C Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
07/31/2012CA2404688C Nuclear factor .kappa.b inducing factor
07/31/2012CA2348624C Adenovirus-mediated gene therapy
07/31/2012CA2341018C Polypeptides and polynucleotides from coagulase-negative staphylococci
07/31/2012CA2223402C Methods of inhibiting phagocytosis
07/26/2012WO2012100248A1 Methods and compositions related to synergistic responses to oncogenic mutations
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 870